FIELD: chemistry of proteins and peptides. SUBSTANCE: analog-agonist of amyline shows an amino acid sequence of the general formula (I): A1-X-Asn-Thr-5Ala-Thr-Ala-Thr-10Gln-Arg--Leu-B1-Asn-15Phe-Leu-C1-D1-E1-20F1-G1-Asn-H1-Gly-25J1-J1-Leu-K1-L1-30Thr-M1-Val-Gly-Ser- -35Asn-Thr-Tyr-Z where A1-M1 mean amino acid residues given in p. 1 of the invention claims. Composition obtained on the basis of compound of the formula (I) shows property of amyline agonist. EFFECT: agonistic property of analog. 10 cl, 2 dwg, 2 tbl, 39 ex
Title | Year | Author | Number |
---|---|---|---|
NEW COMPOSITIONS OF EXENDINE AGONISTS AND METHODS OF THEIR ADMINISTRATION | 2000 |
|
RU2242244C2 |
METHODS OF OBESITY TREATMENT | 1998 |
|
RU2207871C2 |
METHOD FOR TREATMENT OR PROPHYLAXIS OF OBESITY | 2002 |
|
RU2314121C9 |
METHOD FOR TREATING DIABETES TYPE II WITH AMYLENE ANTAGONISTS | 1996 |
|
RU2166958C2 |
METHOD FOR INHIBITING GLUCAGON | 2000 |
|
RU2247575C9 |
METHODS OF REGULATION OF GASTROENTERIC TRACT MOTOR SYSTEM | 1994 |
|
RU2177331C2 |
METHODS OF DIABETES TREATMENT AND BODY WEIGHT REDUCTION | 2006 |
|
RU2421237C2 |
PEPTIDE HAVING AMYLIN PROPERTIES (VERSIONS) AND USE THEREOF (VERSIONS) | 2005 |
|
RU2385878C2 |
DUAL GLP1/GIP OR TRIGONAL GLP1/GIP/GLUCAGON AGONISTS | 2013 |
|
RU2652783C2 |
OXYTOCIN RECEPTOR AGONISTS | 2010 |
|
RU2539692C2 |
Authors
Dates
1999-05-20—Published
1992-11-19—Filed